After more than a decade of short-term cures to erectile dysfunction, most aimed at symptoms rather than the underlying issues of nerve damage, a new approach has emerged from adult stem cell technology developed by RNL Bio. Dr. Ji Youl Lee and the RNL Stem Cell Technology Institute team, working at St. Mary’s Hospital in Seoul, found in animal studies that adipose (fat) derived adult human stem cells, grown in culture, were very effective in treating cavernous nerve injury.
When rats with cavernous nerve injury, the equivalent of erectile dysfunction in humans, were treated with RNL Bio’s patented
For the first time in the United States, stem cells have been directly injected into the spinal cord of a patient, researchers announced Thursday.
Doctors injected stem cells from 8-week-old fetal tissue into the spine of a man in his early 60s who has advanced ALS, or amyotrophic lateral sclerosis. It was part of a clinical trial designed to determine whether it is safe to inject stem cells into the spinal cord and whether the cells themselves are safe (…)
Banks are assisting families with financing so they can preserve umbilical cord stem cells that could be used to fight many diseases and malignant tumors like leukemia, neuroblastoma, and Hodgkin’s disease, and multiple myeloma. This has happened so far in Liguria and the Piedmont, where the Credito Cooperativo bank in Pianfei and Rocca de’ Baldi are present.
The project by an Italian bank in collaboration with Swiss company, Genico, calls of reduced financing rates for expenses related to the cryoconservation of umbilical cord stem cells. About 2,500 euros are needed to collect the cells, transport them to
Progress has been made against strokes thanks to stem cells. British researchers, thanks to these cells, have managed to repair brain tissue damaged by a stroke. The study, financed by the research council on biological and biotechnological sciences of the United Kingdom, was published in Nature Biomaterials. The team from the Institute of Psychiatry at the University of Nottingham, used a biodegradable polymer called Plga to build a scaffold for neural cells.
Using these they filled the cavity left by a stroke. This allows, explained Mike Modo, psychiatrist at King’s College in London and coordinator of
Line is first from U-M accepted to the U.S. National Institutes of Health registry, now available for federally-funded research
The University of Michigan’s first human embryonic stem cell line will be placed on the U.S. National Institutes of Health’s registry, making the cells available for federally-funded research. It is the first of the stem cell lines derived at the University of Michigan to be placed on the registry.
The line, known as UM4-6, is a genetically normal line, derived in October 2010 from a cluster of about 30 cells removed from a donated five-day-old embryo roughly the size of the period